Miller Financial Services’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.45M Sell
23,159
-202
-0.9% -$12.8K 1.1% 20
2026
Q2
$1.35M Buy
23,361
+3,650
+19% +$210K 1.08% 23
2026
Q1
$1.2M Sell
19,711
-269
-1% -$15.7K 1.31% 20
2025
Q4
$1.08M Buy
19,980
+338
+2% +$16.3K 1.26% 22
2025
Q3
$886K Buy
19,642
+738
+4% +$34.5K 1.02% 28
2025
Q2
$875K Buy
18,904
+1,595
+9% +$78.3K 1.12% 24
2025
Q1
$1.06M Sell
17,309
-186
-1% -$10.8K 1.52% 18
2024
Q4
$990K Buy
+17,495
New +$978K 0.84% 30

Other funds holding BMY

Miller Financial Services's BMY Position: Q3 2026 in Review

Miller Financial Services reduced its Bristol-Myers Squibb (BMY) stake by 0.86% in Q3 2026, selling an estimated $12.8K and leaving 23,159 shares worth $1.45M. The position accounts for 1.1% of the portfolio, ranked #20.

Miller Financial Services first reported a position in BMY in Q4 2024 and has held it in 8 quarters since. 1,520 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

  • Miller Financial Services held 23,159 shares of Bristol-Myers Squibb worth $1.45M as of Q3 2026.
  • Miller Financial Services sold 202 Bristol-Myers Squibb shares in Q3 2026, an estimated $12.8K.
  • Bristol-Myers Squibb made up 1.1% of Miller Financial Services's portfolio in Q3 2026, its #20 holding.
  • Miller Financial Services first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 8 quarters since.
  • 1,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on Miller Financial Services's 13F filing for Q3 2026, filed 20 Oct 2026.